A1M/α1-Microglobulin Protects from Heme-Induced Placental and Renal Damage in a Pregnant Sheep Model of Preeclampsia.

Research output: Contribution to journalArticle

Standard

A1M/α1-Microglobulin Protects from Heme-Induced Placental and Renal Damage in a Pregnant Sheep Model of Preeclampsia. / Wester Rosenlöf, Lena; Casslén, Vera; Axelsson, Josefin; Edström, Anneli; Gram, Magnus; Holmqvist, Madlene; Johansson, Martin; Larsson, Irene; Ley, David; Marsal, Karel; Mörgelin, Matthias; Rippe, Bengt; Rutardottir, Sigurbjörg; Shohani, Behnaz; Åkerström, Bo; Hansson, Stefan.

In: PLoS ONE, Vol. 9, No. 1, e86353, 2014.

Research output: Contribution to journalArticle

Harvard

Wester Rosenlöf, L, Casslén, V, Axelsson, J, Edström, A, Gram, M, Holmqvist, M, Johansson, M, Larsson, I, Ley, D, Marsal, K, Mörgelin, M, Rippe, B, Rutardottir, S, Shohani, B, Åkerström, B & Hansson, S 2014, 'A1M/α1-Microglobulin Protects from Heme-Induced Placental and Renal Damage in a Pregnant Sheep Model of Preeclampsia.', PLoS ONE, vol. 9, no. 1, e86353. https://doi.org/10.1371/journal.pone.0086353

APA

Wester Rosenlöf, L., Casslén, V., Axelsson, J., Edström, A., Gram, M., Holmqvist, M., Johansson, M., Larsson, I., Ley, D., Marsal, K., Mörgelin, M., Rippe, B., Rutardottir, S., Shohani, B., Åkerström, B., & Hansson, S. (2014). A1M/α1-Microglobulin Protects from Heme-Induced Placental and Renal Damage in a Pregnant Sheep Model of Preeclampsia. PLoS ONE, 9(1), [e86353]. https://doi.org/10.1371/journal.pone.0086353

CBE

Wester Rosenlöf L, Casslén V, Axelsson J, Edström A, Gram M, Holmqvist M, Johansson M, Larsson I, Ley D, Marsal K, Mörgelin M, Rippe B, Rutardottir S, Shohani B, Åkerström B, Hansson S. 2014. A1M/α1-Microglobulin Protects from Heme-Induced Placental and Renal Damage in a Pregnant Sheep Model of Preeclampsia. PLoS ONE. 9(1):Article e86353. https://doi.org/10.1371/journal.pone.0086353

MLA

Vancouver

Author

Wester Rosenlöf, Lena ; Casslén, Vera ; Axelsson, Josefin ; Edström, Anneli ; Gram, Magnus ; Holmqvist, Madlene ; Johansson, Martin ; Larsson, Irene ; Ley, David ; Marsal, Karel ; Mörgelin, Matthias ; Rippe, Bengt ; Rutardottir, Sigurbjörg ; Shohani, Behnaz ; Åkerström, Bo ; Hansson, Stefan. / A1M/α1-Microglobulin Protects from Heme-Induced Placental and Renal Damage in a Pregnant Sheep Model of Preeclampsia. In: PLoS ONE. 2014 ; Vol. 9, No. 1.

RIS

TY - JOUR

T1 - A1M/α1-Microglobulin Protects from Heme-Induced Placental and Renal Damage in a Pregnant Sheep Model of Preeclampsia.

AU - Wester Rosenlöf, Lena

AU - Casslén, Vera

AU - Axelsson, Josefin

AU - Edström, Anneli

AU - Gram, Magnus

AU - Holmqvist, Madlene

AU - Johansson, Martin

AU - Larsson, Irene

AU - Ley, David

AU - Marsal, Karel

AU - Mörgelin, Matthias

AU - Rippe, Bengt

AU - Rutardottir, Sigurbjörg

AU - Shohani, Behnaz

AU - Åkerström, Bo

AU - Hansson, Stefan

N1 - The information about affiliations in this record was updated in December 2015. The record was previously connected to the following departments: Medical Inflammation Research (013212019), Paediatrics (Lund) (013002000), Department of Obstetrics and Gynaecology (Lund) (013018000), Pathology (Malmö) (013031000), Department of Nephrology (013230024), Division of Infection Medicine (BMC) (013024020)

PY - 2014

Y1 - 2014

N2 - Preeclampsia (PE) is a serious pregnancy complication that manifests as hypertension and proteinuria after the 20(th) gestation week. Previously, fetal hemoglobin (HbF) has been identified as a plausible causative factor. Cell-free Hb and its degradation products are known to cause oxidative stress and tissue damage, typical of the PE placenta. A1M (α1-microglobulin) is an endogenous scavenger of radicals and heme. Here, the usefulness of A1M as a treatment for PE is investigated in the pregnant ewe PE model, in which starvation induces PE symptoms via hemolysis. Eleven ewes, in late pregnancy, were starved for 36 hours and then treated with A1M (n = 5) or placebo (n = 6) injections. After injections, the ewes were re-fed and observed for additional 72 hours. They were monitored for blood pressure, proteinuria, blood cell distribution and clinical and inflammation markers in plasma. Before termination, the utero-placental circulation was analyzed with Doppler velocimetry and the kidney glomerular function was analyzed by Ficoll sieving. At termination, blood, kidney and placenta samples were collected and analyzed for changes in gene expression and tissue structure. The starvation resulted in increased amounts of the hemolysis marker bilirubin in the blood, structural damages to the placenta and kidneys and an increased glomerular sieving coefficient indicating a defect filtration barrier. Treatment with A1M ameliorated these changes without signs of side-effects. In conclusion, A1M displayed positive therapeutic effects in the ewe starvation PE model, and was well tolerated. Therefore, we suggest A1M as a plausible treatment for PE in humans.

AB - Preeclampsia (PE) is a serious pregnancy complication that manifests as hypertension and proteinuria after the 20(th) gestation week. Previously, fetal hemoglobin (HbF) has been identified as a plausible causative factor. Cell-free Hb and its degradation products are known to cause oxidative stress and tissue damage, typical of the PE placenta. A1M (α1-microglobulin) is an endogenous scavenger of radicals and heme. Here, the usefulness of A1M as a treatment for PE is investigated in the pregnant ewe PE model, in which starvation induces PE symptoms via hemolysis. Eleven ewes, in late pregnancy, were starved for 36 hours and then treated with A1M (n = 5) or placebo (n = 6) injections. After injections, the ewes were re-fed and observed for additional 72 hours. They were monitored for blood pressure, proteinuria, blood cell distribution and clinical and inflammation markers in plasma. Before termination, the utero-placental circulation was analyzed with Doppler velocimetry and the kidney glomerular function was analyzed by Ficoll sieving. At termination, blood, kidney and placenta samples were collected and analyzed for changes in gene expression and tissue structure. The starvation resulted in increased amounts of the hemolysis marker bilirubin in the blood, structural damages to the placenta and kidneys and an increased glomerular sieving coefficient indicating a defect filtration barrier. Treatment with A1M ameliorated these changes without signs of side-effects. In conclusion, A1M displayed positive therapeutic effects in the ewe starvation PE model, and was well tolerated. Therefore, we suggest A1M as a plausible treatment for PE in humans.

U2 - 10.1371/journal.pone.0086353

DO - 10.1371/journal.pone.0086353

M3 - Article

VL - 9

JO - PLoS ONE

JF - PLoS ONE

SN - 1932-6203

IS - 1

M1 - e86353

ER -